Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1

Nicole Kieper, Kira M. Holmström, Dalila Ciceri, Fabienne Fiesel, Hartwig Wolburg, Elena Ziviani, Alexander J. Whitworth, L. Miguel Martins, Philipp J. Kahle, Rejko Krüger

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Loss of Omi/HtrA2 function leads to nerve cell loss in mouse models and has been linked to neurodegeneration in Parkinson's and Huntington's disease. Omi/HtrA2 is a serine protease released as a pro-apoptotic factor from the mitochondrial intermembrane space into the cytosol. Under physiological conditions, Omi/HtrA2 is thought to be involved in protection against cellular stress, but the cytological and molecular mechanisms are not clear. Omi/HtrA2 deficiency caused an accumulation of reactive oxygen species and reduced mitochondrial membrane potential. In Omi/HtrA2 knockout mouse embryonic fibroblasts, as well as in Omi/HtrA2 silenced human HeLa cells and Drosophila S2R+ cells, we found elongated mitochondria by live cell imaging. Electron microscopy confirmed the mitochondrial morphology alterations and showed abnormal cristae structure. Examining the levels of proteins involved in mitochondrial fusion, we found a selective up-regulation of more soluble OPA1 protein. Complementation of knockout cells with wild-type Omi/HtrA2 but not with the protease mutant [S306A]Omi/HtrA2 reversed the mitochondrial elongation phenotype and OPA1 alterations. Finally, co-immunoprecipitation showed direct interaction of Omi/HtrA2 with endogenous OPA1. Thus, we show for the first time a direct effect of loss of Omi/HtrA2 on mitochondrial morphology and demonstrate a novel role of this mitochondrial serine protease in the modulation of OPA1. Our results underscore a critical role of impaired mitochondrial dynamics in neurodegenerative disorders.

Original languageEnglish (US)
Pages (from-to)1213-1224
Number of pages12
JournalExperimental Cell Research
Volume316
Issue number7
DOIs
StatePublished - Jan 1 2010
Externally publishedYes

Fingerprint

Mitochondrial Dynamics
Serine Proteases
Mitochondrial Membrane Potential
Huntington Disease
HeLa Cells
Immunoprecipitation
Knockout Mice
Neurodegenerative Diseases
Cytosol
Drosophila
Parkinson Disease
Reactive Oxygen Species
Electron Microscopy
Mitochondria
Proteins
Peptide Hydrolases
Up-Regulation
Fibroblasts
Phenotype
Neurons

Keywords

  • Fusion
  • HtrA2
  • Mitochondria
  • Omi
  • OPA1
  • Parkinson's disease

ASJC Scopus subject areas

  • Cell Biology

Cite this

Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1. / Kieper, Nicole; Holmström, Kira M.; Ciceri, Dalila; Fiesel, Fabienne; Wolburg, Hartwig; Ziviani, Elena; Whitworth, Alexander J.; Martins, L. Miguel; Kahle, Philipp J.; Krüger, Rejko.

In: Experimental Cell Research, Vol. 316, No. 7, 01.01.2010, p. 1213-1224.

Research output: Contribution to journalArticle

Kieper, N, Holmström, KM, Ciceri, D, Fiesel, F, Wolburg, H, Ziviani, E, Whitworth, AJ, Martins, LM, Kahle, PJ & Krüger, R 2010, 'Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1', Experimental Cell Research, vol. 316, no. 7, pp. 1213-1224. https://doi.org/10.1016/j.yexcr.2010.01.005
Kieper, Nicole ; Holmström, Kira M. ; Ciceri, Dalila ; Fiesel, Fabienne ; Wolburg, Hartwig ; Ziviani, Elena ; Whitworth, Alexander J. ; Martins, L. Miguel ; Kahle, Philipp J. ; Krüger, Rejko. / Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1. In: Experimental Cell Research. 2010 ; Vol. 316, No. 7. pp. 1213-1224.
@article{6b70fae2da594ec1a7240f48b15be4b0,
title = "Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1",
abstract = "Loss of Omi/HtrA2 function leads to nerve cell loss in mouse models and has been linked to neurodegeneration in Parkinson's and Huntington's disease. Omi/HtrA2 is a serine protease released as a pro-apoptotic factor from the mitochondrial intermembrane space into the cytosol. Under physiological conditions, Omi/HtrA2 is thought to be involved in protection against cellular stress, but the cytological and molecular mechanisms are not clear. Omi/HtrA2 deficiency caused an accumulation of reactive oxygen species and reduced mitochondrial membrane potential. In Omi/HtrA2 knockout mouse embryonic fibroblasts, as well as in Omi/HtrA2 silenced human HeLa cells and Drosophila S2R+ cells, we found elongated mitochondria by live cell imaging. Electron microscopy confirmed the mitochondrial morphology alterations and showed abnormal cristae structure. Examining the levels of proteins involved in mitochondrial fusion, we found a selective up-regulation of more soluble OPA1 protein. Complementation of knockout cells with wild-type Omi/HtrA2 but not with the protease mutant [S306A]Omi/HtrA2 reversed the mitochondrial elongation phenotype and OPA1 alterations. Finally, co-immunoprecipitation showed direct interaction of Omi/HtrA2 with endogenous OPA1. Thus, we show for the first time a direct effect of loss of Omi/HtrA2 on mitochondrial morphology and demonstrate a novel role of this mitochondrial serine protease in the modulation of OPA1. Our results underscore a critical role of impaired mitochondrial dynamics in neurodegenerative disorders.",
keywords = "Fusion, HtrA2, Mitochondria, Omi, OPA1, Parkinson's disease",
author = "Nicole Kieper and Holmstr{\"o}m, {Kira M.} and Dalila Ciceri and Fabienne Fiesel and Hartwig Wolburg and Elena Ziviani and Whitworth, {Alexander J.} and Martins, {L. Miguel} and Kahle, {Philipp J.} and Rejko Kr{\"u}ger",
year = "2010",
month = "1",
day = "1",
doi = "10.1016/j.yexcr.2010.01.005",
language = "English (US)",
volume = "316",
pages = "1213--1224",
journal = "Experimental Cell Research",
issn = "0014-4827",
publisher = "Academic Press Inc.",
number = "7",

}

TY - JOUR

T1 - Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1

AU - Kieper, Nicole

AU - Holmström, Kira M.

AU - Ciceri, Dalila

AU - Fiesel, Fabienne

AU - Wolburg, Hartwig

AU - Ziviani, Elena

AU - Whitworth, Alexander J.

AU - Martins, L. Miguel

AU - Kahle, Philipp J.

AU - Krüger, Rejko

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Loss of Omi/HtrA2 function leads to nerve cell loss in mouse models and has been linked to neurodegeneration in Parkinson's and Huntington's disease. Omi/HtrA2 is a serine protease released as a pro-apoptotic factor from the mitochondrial intermembrane space into the cytosol. Under physiological conditions, Omi/HtrA2 is thought to be involved in protection against cellular stress, but the cytological and molecular mechanisms are not clear. Omi/HtrA2 deficiency caused an accumulation of reactive oxygen species and reduced mitochondrial membrane potential. In Omi/HtrA2 knockout mouse embryonic fibroblasts, as well as in Omi/HtrA2 silenced human HeLa cells and Drosophila S2R+ cells, we found elongated mitochondria by live cell imaging. Electron microscopy confirmed the mitochondrial morphology alterations and showed abnormal cristae structure. Examining the levels of proteins involved in mitochondrial fusion, we found a selective up-regulation of more soluble OPA1 protein. Complementation of knockout cells with wild-type Omi/HtrA2 but not with the protease mutant [S306A]Omi/HtrA2 reversed the mitochondrial elongation phenotype and OPA1 alterations. Finally, co-immunoprecipitation showed direct interaction of Omi/HtrA2 with endogenous OPA1. Thus, we show for the first time a direct effect of loss of Omi/HtrA2 on mitochondrial morphology and demonstrate a novel role of this mitochondrial serine protease in the modulation of OPA1. Our results underscore a critical role of impaired mitochondrial dynamics in neurodegenerative disorders.

AB - Loss of Omi/HtrA2 function leads to nerve cell loss in mouse models and has been linked to neurodegeneration in Parkinson's and Huntington's disease. Omi/HtrA2 is a serine protease released as a pro-apoptotic factor from the mitochondrial intermembrane space into the cytosol. Under physiological conditions, Omi/HtrA2 is thought to be involved in protection against cellular stress, but the cytological and molecular mechanisms are not clear. Omi/HtrA2 deficiency caused an accumulation of reactive oxygen species and reduced mitochondrial membrane potential. In Omi/HtrA2 knockout mouse embryonic fibroblasts, as well as in Omi/HtrA2 silenced human HeLa cells and Drosophila S2R+ cells, we found elongated mitochondria by live cell imaging. Electron microscopy confirmed the mitochondrial morphology alterations and showed abnormal cristae structure. Examining the levels of proteins involved in mitochondrial fusion, we found a selective up-regulation of more soluble OPA1 protein. Complementation of knockout cells with wild-type Omi/HtrA2 but not with the protease mutant [S306A]Omi/HtrA2 reversed the mitochondrial elongation phenotype and OPA1 alterations. Finally, co-immunoprecipitation showed direct interaction of Omi/HtrA2 with endogenous OPA1. Thus, we show for the first time a direct effect of loss of Omi/HtrA2 on mitochondrial morphology and demonstrate a novel role of this mitochondrial serine protease in the modulation of OPA1. Our results underscore a critical role of impaired mitochondrial dynamics in neurodegenerative disorders.

KW - Fusion

KW - HtrA2

KW - Mitochondria

KW - Omi

KW - OPA1

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=77950616071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950616071&partnerID=8YFLogxK

U2 - 10.1016/j.yexcr.2010.01.005

DO - 10.1016/j.yexcr.2010.01.005

M3 - Article

C2 - 20064504

AN - SCOPUS:77950616071

VL - 316

SP - 1213

EP - 1224

JO - Experimental Cell Research

JF - Experimental Cell Research

SN - 0014-4827

IS - 7

ER -